Overview

This trial is active, not recruiting.

Condition diabetes mellitus
Treatment no intervention is given.
Sponsor University College, London
Start date August 2015
End date October 2015
Trial size 80000 participants
Trial identifier NCT02542774, 15_108R

Summary

To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective

Primary Outcomes

Measure
First occurrence of cardiovascular disease
time frame: 10 years

Secondary Outcomes

Measure
Cardiovascular mortality
time frame: 10 years
All cause mortality
time frame: 10 years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up. - Age ≥ 18 years - Data collected in the period 1997-2010 - Minimum time since registration of 1 year - Minimum of 1 year of up to standard data (CPRD quality standard) Exclusion Criteria: • None

Additional Information

Official title Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes: an Examination of Variation in Health Service Delivery
Description The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes. The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.
Trial information was received from ClinicalTrials.gov and was last updated in September 2015.
Information provided to ClinicalTrials.gov by University College, London.